Sonic Healthcare forecasts 12% profit growth

Net profit for the year is up 6% and revenues grew 4%.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

International medical diagnostics company Sonic Healthcare (ASX: SHL) has reported revenue growth of 4.1% over the past 12 months to $3.48 billion and an increase in net profit after tax of 6% to $335 million. Earnings per share grew 4.5% to 84.3 cents.

Sonic, which specialises in laboratory medicine, pathology and radiology services, also announced a 2 cent increase in the final dividend to 37 cents per share, which takes the full year dividend to 62 cents per share.

Perhaps most pleasing of all was the company's outlook statement. At current exchange rates management is forecasting a 12% increase in earnings before interest, tax, depreciation and amortisation, which could lead to an even higher growth rate in net profit given management also expects interest expense to decline by around 10% in financial year 2014.

Sonic's results add to a steady stream of solid earnings from the health/medical sector. So far this August shareholders in firms including Primary Health Care (ASX: PRY), CSL (ASX: CSL) and ResMed (ASX: RMD) have enjoyed impressive earnings growth and increases in dividends.

Foolish takeaway

With many companies struggling to grow revenues and earnings and a significant number of firms being forced to cut dividend payments to shareholders, the benefits of an investment philosophy which focusses on quality companies that can grow their earnings and dividends through all kinds of economic headwinds is as clear as ever.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tim McArthur owns shares in Primary Health Care.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »